Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBIN HOWARD W −$30K President & CEO sold <1% of stake
  2. Zalevsky Jonathan −$13K Chief R&D Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-02 Labrucherie Gil M SVP, COO & CFO Sale −6,932 $20.96 $145K 268,906
2021-02-02 Labrucherie Gil M SVP, COO & CFO Sale −1,933 $21.66 $42K 266,973
2021-02-02 Labrucherie Gil M SVP, COO & CFO Option exercise · Stock Option −50,000 25,000
2021-01-28 Thomsen Jillian B. SVP & Chief Accounting Officer Option exercise +37,500 $8.80 $330K 213,757
2021-01-28 Thomsen Jillian B. SVP & Chief Accounting Officer Option exercise +37,500 $8.80 $330K 251,257
2021-01-28 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −75,000 $18.62 $1.4M 176,257
2021-01-28 Thomsen Jillian B. SVP & Chief Accounting Officer Option exercise · Stock Option −37,500 0
2021-01-28 Thomsen Jillian B. SVP & Chief Accounting Officer Option exercise · Stock Option −37,500 0
2021-01-05 GREER R SCOTT Director Option exercise +40,000 $13.80 $552K 225,674
2021-01-05 GREER R SCOTT Director Option exercise · Stock Option −40,000 0
2020-12-30 WHITFIELD ROY A Director Gift −51,500 185,850
2020-12-30 WHITFIELD ROY A Director Gift +51,500 51,500
2020-12-18 Zalevsky Jonathan Chief R&D Officer Grant or award +40,000 290,317
2020-12-18 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +71,500 71,500
2020-12-18 Wilson Mark Andrew SVP & General Counsel Grant or award +28,550 78,900
2020-12-18 Wilson Mark Andrew SVP & General Counsel Grant or award · Stock Option +51,000 51,000
2020-12-18 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award +16,000 176,257
2020-12-18 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +28,600 28,600
2020-12-18 ROBIN HOWARD W President & CEO Grant or award +106,650 458,693
2020-12-18 ROBIN HOWARD W President & CEO Grant or award · Stock Option +190,650 190,650

Page 16 of 18 · 355 trades